The Indirect Cause of Mortality in Covid-19 The journal ‘Phage’ recently published a review suggesting the use of bacteriophages in patients with severe Covid-19. According to the review, the indirect cause of mortality in patients with Covid-19 is due to miscommunication between the innate and...
Mutations in the Pandemic Influenza Virus Since seasonal influenza virus is constantly mutating through antigenic shift, it is necessary to develop new vaccines every year, but it could take over 6 months to develop a new vaccine that matches the new virus. In a pandemic...
Development of Robot Bacteriophages with CRISPER-Cas9 Technology iNtRON’s PHAGERUS® Technology iNtRON’s PHAGERUS® technology discovered the applicability of bacteriophage as a virus neutralizing vaccine, and has secured a number of related core technologies from late 2018. Based on this, we are actively investing in PHAGERUS® by launching...
Human Health and Microbiome We need a stable, balanced gut microbiome (GM) to be healthy. Bacteriophages play an important role in maintaining healthy GM function. <Healthy Human Gut Phageome> by Manrique et al., published in PNSAS, investigated the relationship between human health and gut phageome,...
Arixa Pharmaceuticals™, Inc., a company dedicated to developing next-generation oral antibiotics for drug-resistant Gram-negative infections today announced that Pfizer’s Hospital Business has agreed to acquire Arixa. Arixa’s lead compound, ARX-1796, is an oral prodrug of avibactam, a beta lactamase inhibitor (BLI) that was FDA-approved in 2015 as part...
iNtRON Biotechnology has developed a LiliF™ GBN COVID-19 IgG Rapid Kit. LiliF™ GBN COVID-19 IgG Rapid Kit is a lateral flow chromatographic immunoassay for the detection of anti-SARS-CoV-2 IgG antibodies in human whole blood, serum or plasma. It is intended to be used by professionals...